PT-141 (Bremelanotide)
Reported Onset
2–4 weeks
Primary Use
Libido enhancement and sexual arousal in both men and women.
Dose
1mg - 2mg
Frequency
As needed, 45 minutes before activity
Oxytocin
Reported Onset
2–4 weeks
Primary Use
Social bonding enhancement, trust facilitation, and stress reduction.
Dose
10-40 IU
Frequency
As needed
Community Verdict
Both enhance sexual/bonding experience via different CNS pathways. The community generally selects between PT-141 (Bremelanotide) and Oxytocin based on their specific goals and experience. Both compounds are available through physician-supervised protocols at Alukard, where a physician can help determine which is most appropriate for your situation.
Get a Physician-Supervised Protocol for PT-141 (Bremelanotide) or Oxytocin at Alukard
Community experiences are a starting point — but a physician-supervised protocol from Alukard gives you pharmaceutical-grade compounds, proper dosing, lab monitoring, and the safety of medical oversight.
MD
Supervised
GMP
Certified
Labs
Monitoring
COA
Verified